|
US7153827B1
(en)
|
1994-03-08 |
2006-12-26 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2 and methods of use
|
|
US7109308B1
(en)
|
1994-03-08 |
2006-09-19 |
Human Genome Sciences, Inc. |
Antibodies to human vascular endothelial growth factor 2
|
|
US7186688B1
(en)
|
1994-03-08 |
2007-03-06 |
Human Genome Sciences, Inc. |
Methods of stimulating angiogenesis in a patient by administering vascular endothelial growth factor 2
|
|
EP0751992B1
(en)
|
1994-03-08 |
2005-11-09 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
|
US5932540A
(en)
|
1994-03-08 |
1999-08-03 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
|
US6608182B1
(en)
|
1994-03-08 |
2003-08-19 |
Human Genome Sciences, Inc. |
Human vascular endothelial growth factor 2
|
|
US6040157A
(en)
|
1994-03-08 |
2000-03-21 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
|
US7223724B1
(en)
|
1999-02-08 |
2007-05-29 |
Human Genome Sciences, Inc. |
Use of vascular endothelial growth factor to treat photoreceptor cells
|
|
PL356836A1
(en)
|
2000-02-10 |
2004-07-12 |
Abbott Laboratories |
Antibodies that bind human interleukin-18 and methods of making and using
|
|
NZ535299A
(en)
*
|
2000-02-21 |
2006-06-30 |
Applied Research Systems |
Use of IL-18 inhibitors
|
|
US20020025317A1
(en)
*
|
2000-07-20 |
2002-02-28 |
Schering Ag |
Bispecific monoclonal antibodies to IL-12 and IL-18
|
|
US7273751B2
(en)
|
2000-08-04 |
2007-09-25 |
Human Genome Science, Inc. |
Vascular endothelial growth factor-2
|
|
KR100857376B1
(ko)
*
|
2001-01-29 |
2008-09-05 |
라보라토리스 세로노 에스.에이. |
심장 질환의 치료 및/또는 예방에 사용되는 ｉｌ-18저해물질
|
|
DE60236646D1
(de)
*
|
2001-04-13 |
2010-07-22 |
Human Genome Sciences Inc |
Anti-VEGF-2 Antikörper
|
|
US7402312B2
(en)
|
2001-04-13 |
2008-07-22 |
Human Genome Sciences, Inc. |
Antibodies to vascular endothelial growth factor 2 (VEGF-2)
|
|
CN100556450C
(zh)
*
|
2001-05-16 |
2009-11-04 |
耶达研究发展有限公司 |
Il-18抑制剂在治疗或预防脓毒症中的应用
|
|
US20040213786A1
(en)
*
|
2001-08-24 |
2004-10-28 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions and methods for treating T-cell mediated autoimmune diseases
|
|
RU2318829C2
(ru)
|
2001-11-14 |
2008-03-10 |
Сентокор, Инк. |
Антитела против il-6, композиции, способы и применение
|
|
EP1494710A4
(en)
*
|
2002-03-26 |
2007-03-21 |
Centocor Inc |
DIABETES-RELEVANT IMMUNOGLOBULIN-BASED PROTEINS, COMPOSITIONS, PROCESSES AND USES
|
|
AU2002247905A1
(en)
*
|
2002-03-28 |
2003-10-13 |
Markus Fritzsche |
Antibody against an epitope of the b. burgdorferi flagellar basal rod protein (fbrp)
|
|
US7253260B2
(en)
*
|
2002-04-17 |
2007-08-07 |
Smithkline Beecham Corporation |
Human IL-18 crystal structure
|
|
US7601351B1
(en)
|
2002-06-26 |
2009-10-13 |
Human Genome Sciences, Inc. |
Antibodies against protective antigen
|
|
AU2003256299A1
(en)
|
2002-07-01 |
2004-01-19 |
Human Genome Sciences, Inc. |
Antibodies that specifically bind to reg iv
|
|
US20050271660A1
(en)
|
2002-09-06 |
2005-12-08 |
Alexion Pharmaceuticals, Inc. |
Nebulization of monoclonal antibodies for treating pulmonary diseases
|
|
US9415102B2
(en)
|
2002-09-06 |
2016-08-16 |
Alexion Pharmaceuticals, Inc. |
High concentration formulations of anti-C5 antibodies
|
|
US7261893B2
(en)
|
2002-10-22 |
2007-08-28 |
Wyeth |
Neutralizing antibodies against GDF-8 and uses therefor
|
|
US9320792B2
(en)
|
2002-11-08 |
2016-04-26 |
Ablynx N.V. |
Pulmonary administration of immunoglobulin single variable domains and constructs thereof
|
|
EP1558647B1
(en)
*
|
2002-11-08 |
2015-06-10 |
Ablynx N.V. |
Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
|
|
EP2284192A3
(en)
|
2002-11-08 |
2011-07-20 |
Ablynx N.V. |
Camelidae antibodies for sublingual administration
|
|
US20060034845A1
(en)
|
2002-11-08 |
2006-02-16 |
Karen Silence |
Single domain antibodies directed against tumor necrosis factor alpha and uses therefor
|
|
CA2523912A1
(en)
*
|
2003-04-30 |
2004-11-11 |
Japan Science And Technology Agency |
Human antihuman interleukin-18 antibody, fragment thereof and method of using the same
|
|
GB0323965D0
(en)
*
|
2003-10-13 |
2003-11-19 |
Glaxosmithkline Biolog Sa |
Immunogenic compositions
|
|
US7968684B2
(en)
*
|
2003-11-12 |
2011-06-28 |
Abbott Laboratories |
IL-18 binding proteins
|
|
US20050100965A1
(en)
*
|
2003-11-12 |
2005-05-12 |
Tariq Ghayur |
IL-18 binding proteins
|
|
AU2011224023C1
(en)
*
|
2003-11-12 |
2013-08-29 |
Abbvie Inc. |
IL-18 binding proteins
|
|
US20050227289A1
(en)
|
2004-04-09 |
2005-10-13 |
Reilly Edward B |
Antibodies to erythropoietin receptor and uses thereof
|
|
EP1780542A4
(en)
*
|
2004-06-30 |
2008-05-14 |
Atsuo Sekiyama |
AGENT INDICATING A NON-INFLAMMATORY RESPONSE TO A STRESS AND USE THEREOF
|
|
US7141382B1
(en)
|
2004-10-12 |
2006-11-28 |
Parikh Chirag R |
Methods for detection of IL-18 as an early marker for diagnosis of acute renal failure and predictor of mortality
|
|
PA8672101A1
(es)
|
2005-04-29 |
2006-12-07 |
Centocor Inc |
Anticuerpos anti-il-6, composiciones, métodos y usos
|
|
EP2500353A3
(en)
|
2005-08-19 |
2012-10-10 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
JP5364870B2
(ja)
|
2005-08-19 |
2013-12-11 |
アッヴィ・インコーポレイテッド |
二重可変ドメイン免疫グロブリン及びその使用
|
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
CN101277974A
(zh)
|
2005-09-30 |
2008-10-01 |
阿伯特有限及两合公司 |
排斥性引导分子(rgm)蛋白质家族的蛋白质的结合结构域及其功能性片段和它们的用途
|
|
HUE039865T2
(hu)
*
|
2005-12-20 |
2019-02-28 |
Sbi Biotech Co Ltd |
Anti-ILT7 antitest
|
|
TWI417301B
(zh)
*
|
2006-02-21 |
2013-12-01 |
Wyeth Corp |
對抗人類介白素-２２（ｉｌ-２２）之抗體及其用途
|
|
AU2007267213B2
(en)
*
|
2006-05-25 |
2012-03-29 |
Glaxo Group Limited |
Modified humanised anti-interleukin-18 antibodies
|
|
MX353340B
(es)
|
2006-09-13 |
2018-01-09 |
Abbvie Inc |
Mejoras de cultivos celulares.
|
|
US8911964B2
(en)
|
2006-09-13 |
2014-12-16 |
Abbvie Inc. |
Fed-batch method of making human anti-TNF-alpha antibody
|
|
EP2500414A1
(en)
|
2006-09-13 |
2012-09-19 |
Abbott Laboratories |
Cell culture improvements
|
|
EP2115035B1
(en)
|
2007-01-04 |
2018-04-25 |
SK Chemicals Co., Ltd. |
Polyarylene sulfide resin with excellent luminosity and preparation method thereof
|
|
WO2008150431A1
(en)
*
|
2007-05-29 |
2008-12-11 |
Yale University |
Il- 18 and protein kinase r inhibition for the treatment of copd
|
|
CL2008002153A1
(es)
|
2007-07-24 |
2009-06-05 |
Amgen Inc |
Anticuerpo aislado o fragmanto de unión de antigeno del mismo que se une al receptor de il-18 (il-18r); molecula de ácido nucleico codificante; celula huesped que la comprende; composición farmaceutica; uso médico para tratar o prevenir una condición asociada con il-18r; método in vitro para inhibir la unión de il-18 al il-18r.
|
|
ES2539026T3
(es)
|
2007-12-27 |
2015-06-25 |
Abbott Laboratories |
Anticuerpos anti-T. cruzi y métodos de uso
|
|
US8962803B2
(en)
|
2008-02-29 |
2015-02-24 |
AbbVie Deutschland GmbH & Co. KG |
Antibodies against the RGM A protein and uses thereof
|
|
JP5646457B2
(ja)
|
2008-04-29 |
2014-12-24 |
アッヴィ・インコーポレイテッド |
二重可変ドメイン免疫グロブリン及びその使用
|
|
PE20100054A1
(es)
|
2008-06-03 |
2010-03-03 |
Abbott Lab |
Inmunoglobulina con dominio variable dual
|
|
EP3002299A1
(en)
|
2008-06-03 |
2016-04-06 |
AbbVie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
|
US8188235B2
(en)
|
2008-06-18 |
2012-05-29 |
Pfizer Inc. |
Antibodies to IL-6 and their uses
|
|
MX2010014574A
(es)
|
2008-07-08 |
2011-04-27 |
Abbott Lab |
Inmunoglobulinas de dominio variable dual para prostaglandina e2 y usos de las mismas.
|
|
WO2010048190A2
(en)
*
|
2008-10-20 |
2010-04-29 |
Abbott Laboratories |
Antibodies that bind to il-12 and methods of purifying the same
|
|
EP2346901A1
(en)
*
|
2008-10-20 |
2011-07-27 |
Abbott Laboratories |
Antibodies that bind to il-18 and methods of purifying the same
|
|
TW201024318A
(en)
*
|
2008-10-20 |
2010-07-01 |
Abbott Lab |
Isolation and purification of antibodies using protein A affinity chromatography
|
|
SG195577A1
(en)
*
|
2008-10-20 |
2013-12-30 |
Abbott Lab |
Viral inactivation during purification of antibodies
|
|
KR101593285B1
(ko)
|
2008-10-29 |
2016-02-11 |
아블린쓰 엔.브이. |
단일 도메인 항원 결합 분자의 제형
|
|
CA2739352C
(en)
|
2008-10-29 |
2021-07-13 |
Wyeth Llc |
Methods for purification of single domain antigen binding molecules
|
|
US8168165B2
(en)
|
2008-12-23 |
2012-05-01 |
Abbott Laboratories |
Alkylated interleukin-18 compositions
|
|
US8349325B2
(en)
|
2008-12-23 |
2013-01-08 |
Abbott Laboratories |
Soluble FMS-like tyrosine kinase-1 (sFLT-1) antibody and related composition, kit, methods of using, and materials and method for making
|
|
AR078254A1
(es)
|
2009-09-01 |
2011-10-26 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
|
MX2012004415A
(es)
|
2009-10-15 |
2012-05-08 |
Abbott Lab |
Inmunoglobulinas de dominio variable doble y usos de las mismas.
|
|
UY32979A
(es)
|
2009-10-28 |
2011-02-28 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
|
KR20120118002A
(ko)
|
2009-12-08 |
2012-10-25 |
애보트 게엠베하 운트 콤파니 카게 |
망막 신경 섬유 층 변성의 치료에 사용하기 위한 ｒｇｍ ａ 단백질에 대한 모노클로날 항체
|
|
US20120308564A1
(en)
*
|
2010-02-09 |
2012-12-06 |
Andrew Ian Bayliffe |
Treatment of a metabolic disorder
|
|
US20110229921A1
(en)
|
2010-03-18 |
2011-09-22 |
Abbott Laboratories |
METHODS OF ASSAYING URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (uNGAL) IN THE PROGNOSIS OF CADAVERIC KIDNEY TRANSPLANT FUNCTION IN A PATIENT, INCLUDING A PATIENT DIAGNOSED WITH DELAYED GRAFT FUNCTION (DGF), A METHOD OF ASSAYING uNGAL IN THE ASSESSMENT OF RISK OF DGF IN A PATIENT DIAGNOSED WITH EARLY GRAFT FUNCTION (EGF), AND RELATED KITS
|
|
US8735546B2
(en)
|
2010-08-03 |
2014-05-27 |
Abbvie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
|
PH12013500337A1
(en)
|
2010-08-26 |
2017-08-23 |
Abbvie Inc |
Dual variable domain immunoglobulins and uses thereof
|
|
CN102443063B
(zh)
*
|
2010-09-30 |
2013-10-23 |
成都康弘生物科技有限公司 |
抗TNFα的人源化Fab和人源化抗体及其用途
|
|
US20120115244A1
(en)
|
2010-11-09 |
2012-05-10 |
Abbott Laboratories |
Materials and methods for immunoassay of pterins
|
|
CA2822515C
(en)
*
|
2010-12-20 |
2023-04-25 |
Medimmune Limited |
Anti-il-18 antibodies and their uses
|
|
CA2822288A1
(en)
*
|
2010-12-22 |
2012-06-28 |
Medimmune, Llc |
Anti-c5/c5a/c5adesr antibodies and fragments
|
|
KR101839640B1
(ko)
|
2011-01-11 |
2018-03-16 |
제이에스알 가부시끼가이샤 |
감방사선성 수지 조성물 및 감방사선성 산 발생제
|
|
US9062106B2
(en)
|
2011-04-27 |
2015-06-23 |
Abbvie Inc. |
Methods for controlling the galactosylation profile of recombinantly-expressed proteins
|
|
EP2791175A2
(en)
|
2011-12-14 |
2014-10-22 |
Abbvie Deutschland GmbH & Co. KG |
Composition and method for the diagnosis and treatment of iron-related disorders
|
|
CN104144947B
(zh)
|
2011-12-14 |
2017-10-27 |
艾伯维德国有限责任两合公司 |
用于诊断和治疗铁相关病症的组合物和方法
|
|
US9120870B2
(en)
|
2011-12-30 |
2015-09-01 |
Abbvie Inc. |
Dual specific binding proteins directed against IL-13 and IL-17
|
|
US8993248B2
(en)
|
2011-12-31 |
2015-03-31 |
Abbott Laboratories |
Truncated human vitamin D binding protein and mutation and fusion thereof and related materials and methods of use
|
|
EP3369746A1
(en)
|
2012-01-27 |
2018-09-05 |
AbbVie Deutschland GmbH & Co KG |
Composition and method for diagnosis and treatment of diseases associated with neurite degeneration
|
|
WO2013158273A1
(en)
|
2012-04-20 |
2013-10-24 |
Abbvie Inc. |
Methods to modulate c-terminal lysine variant distribution
|
|
US9067990B2
(en)
|
2013-03-14 |
2015-06-30 |
Abbvie, Inc. |
Protein purification using displacement chromatography
|
|
WO2013158279A1
(en)
|
2012-04-20 |
2013-10-24 |
Abbvie Inc. |
Protein purification methods to reduce acidic species
|
|
US9249182B2
(en)
|
2012-05-24 |
2016-02-02 |
Abbvie, Inc. |
Purification of antibodies using hydrophobic interaction chromatography
|
|
KR20150043523A
(ko)
|
2012-09-02 |
2015-04-22 |
애브비 인코포레이티드 |
단백질 불균일성의 제어 방법
|
|
US9512214B2
(en)
|
2012-09-02 |
2016-12-06 |
Abbvie, Inc. |
Methods to control protein heterogeneity
|
|
US9376489B2
(en)
|
2012-09-07 |
2016-06-28 |
Novartis Ag |
IL-18 binding molecules
|
|
AU2013337775B2
(en)
|
2012-11-01 |
2017-03-30 |
Abbvie Inc. |
Anti-VEGF/DLL4 dual variable domain immunoglobulins and uses thereof
|
|
ES2742413T3
(es)
*
|
2012-11-21 |
2020-02-14 |
Km Biologics Co Ltd |
Nuevo anticuerpo humano contra IL-18
|
|
CN105102978B
(zh)
|
2013-02-02 |
2018-11-02 |
杜克大学 |
分离循环肿瘤细胞的方法
|
|
SG11201507230PA
(en)
|
2013-03-12 |
2015-10-29 |
Abbvie Inc |
Human antibodies that bind human tnf-alpha and methods of preparing the same
|
|
WO2014151878A2
(en)
|
2013-03-14 |
2014-09-25 |
Abbvie Inc. |
Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
|
|
US8921526B2
(en)
|
2013-03-14 |
2014-12-30 |
Abbvie, Inc. |
Mutated anti-TNFα antibodies and methods of their use
|
|
US9017687B1
(en)
|
2013-10-18 |
2015-04-28 |
Abbvie, Inc. |
Low acidic species compositions and methods for producing and using the same using displacement chromatography
|
|
US9469686B2
(en)
|
2013-03-15 |
2016-10-18 |
Abbott Laboratories |
Anti-GP73 monoclonal antibodies and methods of obtaining the same
|
|
EP2970459A2
(en)
|
2013-03-15 |
2016-01-20 |
AbbVie Inc. |
Dual specific binding proteins directed against il-1beta and il-17
|
|
WO2014197885A2
(en)
|
2013-06-07 |
2014-12-11 |
Duke University |
Inhibitors of complement factor h
|
|
WO2015031626A1
(en)
|
2013-08-28 |
2015-03-05 |
Abbvie Inc. |
Soluble cmet assay
|
|
PT3041864T
(pt)
|
2013-09-05 |
2021-10-26 |
Ab2 Bio Sa |
Proteína de ligação a il-18 (il-18bp) em doenças inflamatórias
|
|
JP2016533318A
(ja)
|
2013-09-17 |
2016-10-27 |
ユニバーシティ ヘルス ネットワーク （ユーエイチエヌ）： テクノロジー ディベロップメント アンド コマーシャリゼーション |
Ｒｇｍａ／ネオジェニンのシス相互作用又は脂質ラフトを標的とする剤及び治療方法における該剤の使用
|
|
EP3052640A2
(en)
|
2013-10-04 |
2016-08-10 |
AbbVie Inc. |
Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
|
|
US8946395B1
(en)
|
2013-10-18 |
2015-02-03 |
Abbvie Inc. |
Purification of proteins using hydrophobic interaction chromatography
|
|
US9085618B2
(en)
|
2013-10-18 |
2015-07-21 |
Abbvie, Inc. |
Low acidic species compositions and methods for producing and using the same
|
|
US9181337B2
(en)
|
2013-10-18 |
2015-11-10 |
Abbvie, Inc. |
Modulated lysine variant species compositions and methods for producing and using the same
|
|
WO2015073884A2
(en)
|
2013-11-15 |
2015-05-21 |
Abbvie, Inc. |
Glycoengineered binding protein compositions
|
|
WO2016044736A1
(en)
*
|
2014-09-18 |
2016-03-24 |
Cell Signaling Technology, Inc. |
Altered antibodies and methods of making the same
|
|
WO2016061632A1
(en)
*
|
2014-10-23 |
2016-04-28 |
La Trobe University |
Fn14-binding proteins and uses thereof
|
|
US10093733B2
(en)
|
2014-12-11 |
2018-10-09 |
Abbvie Inc. |
LRP-8 binding dual variable domain immunoglobulin proteins
|
|
UA128752C2
(uk)
|
2015-03-05 |
2024-10-16 |
Аб2 Біо Са |
Фармацевтична композиція для лікування асоційованого з il-18 захворювання або порушення
|
|
RU2719033C2
(ru)
|
2015-04-23 |
2020-04-16 |
Нантомикс, Ллс |
Способ получения фармацевтического агента для иммунотерапии рака
|
|
TW201710286A
(zh)
|
2015-06-15 |
2017-03-16 |
艾伯維有限公司 |
抗ｖｅｇｆ、ｐｄｇｆ及／或其受體之結合蛋白
|
|
BR112018004867A2
(pt)
|
2015-09-11 |
2018-10-16 |
Abbvie Deutschland |
métodos para tratamento das formas recorrentes de esclerose múltipla
|
|
WO2017087768A1
(en)
|
2015-11-18 |
2017-05-26 |
Duke University |
Targeted delivery of interleukin-10 to tumor infiltrating lymphocytes
|
|
JP6979976B2
(ja)
|
2016-03-10 |
2021-12-15 |
ヴィエラ バイオ，インコーポレーテッド |
Ｉｌｔ７結合分子及びその使用方法
|
|
JP2019517480A
(ja)
|
2016-06-01 |
2019-06-24 |
アッヴィ・インコーポレイテッド |
脊髄損傷及び疼痛を処置するための抗ＲＧＭａ（Ｒｅｐｕｌｓｉｖｅ Ｇｕｉｄａｎｃｅ Ｍｏｌｅｃｕｌｅ Ａ）アンタゴニスト抗体
|
|
WO2017218911A1
(en)
|
2016-06-17 |
2017-12-21 |
Abbott Laboratories |
BIOMARKERS TO PREDICT NEW ONSET HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFpEF)
|
|
EP3279667A1
(en)
|
2016-08-02 |
2018-02-07 |
Abbott Laboratories |
Cardiac troponin i and copeptin as biomarkers for short-term mortality in acute exacerbation of chronic obstructive pulmonary disease (aecopd)
|
|
EP4521116A3
(en)
|
2016-10-03 |
2025-05-28 |
Abbott Laboratories |
Improved methods of assessing uch-l1 status in patient samples
|
|
US10324041B2
(en)
|
2016-12-21 |
2019-06-18 |
Abbott Japan Co., Ltd. |
Optical imaging system using lateral illumination for digital assays
|
|
US11047854B2
(en)
|
2017-02-06 |
2021-06-29 |
Abbott Japan Llc |
Methods for reducing noise in signal-generating digital assays
|
|
JP2020506405A
(ja)
|
2017-02-08 |
2020-02-27 |
シルバイオテック・インコーポレイテッド |
乳がんリスクを判定する方法
|
|
ES3042097T3
(en)
|
2017-03-09 |
2025-11-18 |
Mab Discovery Gmbh |
Antibodies specifically binding to human il-1r7
|
|
CA3261113A1
(en)
|
2017-03-23 |
2025-10-27 |
Abbott Laboratories |
Methods for aiding in the diagnosis and determination of the extent of traumatic brain injury in a human subject using the early biomarker ubiquitin carboxy-terminal hydrolase l1
|
|
CN110546513A
(zh)
|
2017-04-15 |
2019-12-06 |
雅培实验室 |
使用早期生物标记物帮助超急性诊断和确定人类受试者中的创伤性脑损伤的方法
|
|
ES3053676T3
(en)
|
2017-04-28 |
2026-01-23 |
Abbott Lab |
Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury using early biomarkers on at least two samples from the same human subject
|
|
US10865238B1
(en)
|
2017-05-05 |
2020-12-15 |
Duke University |
Complement factor H antibodies
|
|
AU2018272054B2
(en)
|
2017-05-25 |
2024-10-31 |
Abbott Laboratories |
Methods for aiding in the determination of whether to perform imaging on a human subject who has sustained or may have sustained an injury to the head using early biomarkers
|
|
JP7269182B2
(ja)
|
2017-05-30 |
2023-05-08 |
アボット・ラボラトリーズ |
心臓トロポニンｉ及び早期バイオマーカーを使用する、ヒト対象における軽度外傷性脳損傷を診断及び査定する一助となるための方法
|
|
CA3068041C
(en)
|
2017-07-03 |
2024-06-25 |
Abbott Laboratories |
Improved methods for measuring ubiquitin carboxy-terminal hydrolase l1 levels in blood
|
|
US11426389B2
(en)
|
2017-07-28 |
2022-08-30 |
Duke University |
Compositions and methods for promoting hematopoietic stem cell regeneration
|
|
US11022617B2
(en)
|
2017-12-09 |
2021-06-01 |
Abbott Laboratories |
Methods for aiding in the diagnosis and evaluation of a subject who has sustained an orthopedic injury and that has or may have sustained an injury to the head, such as mild traumatic brain injury (TBI), using glial fibrillary acidic protein (GFAP) and/or ubiquitin carboxy-terminal hydrolase L1 (UCH-L1)
|
|
EP3721234A1
(en)
|
2017-12-09 |
2020-10-14 |
Abbott Laboratories |
Methods for aiding in diagnosing and evaluating a traumatic brain injury in a human subject using a combination of gfap and uch-l1
|
|
AU2018395255B2
(en)
|
2017-12-29 |
2025-02-20 |
Abbott Laboratories |
Novel biomarkers and methods for diagnosing and evaluating traumatic brain injury
|
|
JPWO2019194217A1
(ja)
*
|
2018-04-04 |
2021-04-15 |
株式会社ｍＡｂＰｒｏｔｅｉｎ |
検出感度の高いインターロイキン−１８タンパク質に対する抗体及びその応用
|
|
GB201809699D0
(en)
*
|
2018-06-13 |
2018-08-01 |
Singapore Health Serv Pte Ltd |
IL-11 antibodies
|
|
US12269874B2
(en)
|
2018-12-03 |
2025-04-08 |
mAbProtein Co., Ltd. |
Antibody that recognizes neoepitope of activated interleukin-18 proteins and application thereof
|
|
WO2020132536A1
(en)
|
2018-12-20 |
2020-06-25 |
The University Of Chicago |
Compositions and methods related to site-specific identification of rna modifications
|
|
US11079395B2
(en)
|
2019-03-01 |
2021-08-03 |
Abbott Laboratories |
Methods for predicting major adverse cardiovascular events in subjects with coronary artery disease
|
|
KR102265432B1
(ko)
*
|
2019-08-20 |
2021-06-15 |
주식회사 케어젠 |
피부 미백 활성을 갖는 펩타이드 및 이의 용도
|
|
WO2021211331A1
(en)
|
2020-04-13 |
2021-10-21 |
Abbott Point Of Care Inc. |
METHODS, COMPLEXES AND KITS FOR DETECTING OR DETERMINING AN AMOUNT OF A ß-CORONAVIRUS ANTIBODY IN A SAMPLE
|
|
KR20230012539A
(ko)
|
2020-05-13 |
2023-01-26 |
디스크 메디슨, 인크. |
골수섬유증을 치료하기 위한 항-헤모주벨린 (hjv) 항체
|
|
EP4193149A1
(en)
|
2020-08-04 |
2023-06-14 |
Abbott Laboratories |
Improved methods and kits for detecting sars-cov-2 protein in a sample
|
|
EP4193151A1
(en)
|
2020-08-04 |
2023-06-14 |
Abbott Rapid Diagnostics International Unlimited Company |
Assays for detecting sars-cov-2
|
|
CN114773466B
(zh)
*
|
2020-11-26 |
2023-08-29 |
江苏荃信生物医药股份有限公司 |
一种抗人白介素23及包含其的试剂盒及其检测方法
|
|
WO2023102384A1
(en)
|
2021-11-30 |
2023-06-08 |
Abbott Laboratories |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
|
|
CA3198161A1
(en)
|
2020-12-01 |
2022-06-09 |
Beth MCQUISTON |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
|
|
WO2022147178A1
(en)
|
2020-12-30 |
2022-07-07 |
Abbott Laboratories |
Improved methods, reagents and kits for detergent-based inactivation of betacoronavirus prior to and/or while assessing a biological sample for sars-cov-2 antigen or antibody
|
|
EP4271998A1
(en)
|
2020-12-30 |
2023-11-08 |
Abbott Laboratories |
Methods for determining sars-cov-2 antigen and anti-sars-cov-2 antibody in a sample
|
|
CA3214962A1
(en)
*
|
2021-03-26 |
2022-09-29 |
The General Hospital Corporation |
Humanized mab107
|
|
EP4067375A1
(en)
*
|
2021-03-30 |
2022-10-05 |
Universität Ulm |
Fibril peptides
|
|
US20220381796A1
(en)
|
2021-05-18 |
2022-12-01 |
Abbott Laboratories |
Methods of evaluating brain injury in a pediatric subject
|
|
EP4356129A1
(en)
|
2021-06-14 |
2024-04-24 |
Abbott Laboratories |
Methods of diagnosing or aiding in diagnosis of brain injury caused by acoustic energy, electromagnetic energy, an over pressurization wave, and/or blast wind
|
|
EP4371573A4
(en)
|
2021-07-13 |
2025-08-20 |
National Univ Corporation Tokai National Higher Education And Research System |
MEDICINAL COMPOSITION FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
|
|
EP4392783A1
(en)
|
2021-08-27 |
2024-07-03 |
Abbott Laboratories |
Methods for detecting immunoglobulin g, subclass 4 (igg4) in a biological sample
|
|
CN118715440A
(zh)
|
2021-08-31 |
2024-09-27 |
雅培实验室 |
诊断脑损伤的方法和系统
|
|
EP4396587A1
(en)
|
2021-08-31 |
2024-07-10 |
Abbott Laboratories |
Methods and systems of diagnosing brain injury
|
|
EP4409294A1
(en)
|
2021-09-30 |
2024-08-07 |
Abbott Laboratories |
Methods and systems of diagnosing brain injury
|
|
WO2023114978A1
(en)
|
2021-12-17 |
2023-06-22 |
Abbott Laboratories |
Systems and methods for determining uch-l1, gfap, and other biomarkers in blood samples
|
|
EP4473311A1
(en)
|
2022-02-04 |
2024-12-11 |
Abbott Laboratories |
Lateral flow methods, assays, and devices for detecting the presence or measuring the amount of ubiquitin carboxy-terminal hydrolase l1 and/or glial fibrillary acidic protein in a sample
|
|
AU2023226005A1
(en)
*
|
2022-02-23 |
2024-08-29 |
Bright Peak Therapeutics Ag |
Activatable il-18 polypeptides
|
|
CA3257731A1
(en)
|
2022-06-29 |
2024-01-04 |
Abbott Laboratories |
OUTSIDE THE LABORATORY, MAGNETIC SYSTEMS AND ANALYSES FOR DETERMINING GLIOFIBRILLARY ACID PROTEIN IN BIOLOGICAL SAMPLES
|
|
JP2025532597A
(ja)
|
2022-09-15 |
2025-10-01 |
アボット・ラボラトリーズ |
軽度及び超軽度の外傷性脳損傷を区別するためのバイオマーカー及び方法
|
|
WO2024102383A1
(en)
|
2022-11-10 |
2024-05-16 |
Abbott Laboratories |
Methods of identifying macrotroponin in biological samples
|
|
WO2024211475A1
(en)
|
2023-04-04 |
2024-10-10 |
Abbott Laboratories |
Use of biomarkers to determine whether a subject has sustained, may have sustained or is suspected of sustaining a subacute acquired brain injury (abi)
|
|
KR20260003222A
(ko)
|
2023-04-28 |
2026-01-06 |
아보트 러보러터리즈 |
말기 간세포 암종의 진단
|
|
EP4713682A1
(en)
|
2023-04-28 |
2026-03-25 |
Abbott Point of Care Inc. |
Improved assays, cartridges, and kits for detection of biomarkers, including brain injury biomarkers
|
|
WO2024243819A1
(zh)
*
|
2023-05-30 |
2024-12-05 |
上海洛启生物医药技术有限公司 |
抗白介素18受体的纳米抗体及其应用
|
|
CN120518762B
(zh)
*
|
2023-06-05 |
2025-12-26 |
北京东方百泰生物科技股份有限公司 |
一种结合il-11的抗体、其抗原结合片段及应用
|
|
CN121586728A
(zh)
|
2023-06-20 |
2026-02-27 |
阿波罗Ap43有限公司 |
用于治疗特应性皮炎的抗il-18抗体疗法
|
|
WO2025081059A1
(en)
*
|
2023-10-13 |
2025-04-17 |
The Regents Of The University Of Michigan |
Carriers for drug conjugates
|
|
WO2025111147A1
(en)
|
2023-11-21 |
2025-05-30 |
Abbott Laboratories |
Two-dimensional matrix droplet array
|
|
WO2025111148A1
(en)
|
2023-11-21 |
2025-05-30 |
Abbott Laboratories |
Sample analysis device and methods
|
|
WO2025145020A2
(en)
|
2023-12-28 |
2025-07-03 |
Abbott Laboratories |
Methods, systems, compounds, and kits for determining an analyte of interest in a test sample
|
|
WO2025193825A1
(en)
|
2024-03-13 |
2025-09-18 |
Abbott Laboratories |
Diagnosis and monitoring of liver disease
|
|
WO2025191541A1
(en)
|
2024-03-15 |
2025-09-18 |
Tocris Cookson Limited |
Horseradish peroxidase copolymers, conjugates, and uses thereof
|
|
WO2025198859A1
(en)
|
2024-03-21 |
2025-09-25 |
Abbott Laboratories |
Synthesis of thyroid hormone derivatives and their role as calibrators for thyroid hormone immunoassays
|
|
WO2025230857A1
(en)
|
2024-05-01 |
2025-11-06 |
Abbott Laboratories |
Improved methods for determining cardiac myosin binding protein c in biological samples
|
|
WO2025229563A1
(en)
*
|
2024-05-03 |
2025-11-06 |
Glaxosmithkline Intellectual Property Development Limited |
Methods of treating inflammatory bowel disease
|